Bridge Bank expanded its relationship with Tabula Rasa Healthcare, a healthcare technology company optimizing medication safety, through a new $40 million credit facility. The new credit facility will support Tabula Rasa’s pursuit to improve healthcare and their recent acquisition of SinfoniaRX.

“Tabula Rasa Healthcare continues its impressive growth and the SinfoniaRX acquisition is a great fit for the company,” said Alan Spurgin, senior vice president and region director of Bridge Bank’s Mid-Atlantic technology banking group. “We are thrilled to be able to finance this strategic transaction and to expand the relationship between Bridge Bank and Tabula Rasa Healthcare.”

“We appreciated the attention and confidence that we received from Bridge Bank,” said Brian Adams, chief financial officer of Tabula Rasa Healthcare. “Their confidence in us and our team will help lead to the continued growth of our company as we move forward.”